Patent 11027072 was granted and assigned to Adamis Pharmaceuticals Corporation on June, 2021 by the United States Patent and Trademark Office.
Described herein are syringe devices comprising a syringe including a therapeutic dose of at least one drug to be used in a drug or substance overdose. Also provided herein are compositions and methods of treating opioid overdose using high dose naloxone.